dostarlimab
gsk
['dostarlimab', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'rectal']
'unprecedented' 100% of first 14 untreated patients with rectal cancer respond to pd-1 blocker dostarlimab-gxly #crcsm #oncology #cancer #immunotherapy #asco22
News and views from the world of clinical oncology and hematology